Broadfin Capital LLC boosted its position in shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) by 4.0% during the fourth quarter, Holdings Channel reports. The fund owned 5,398,794 shares of the specialty pharmaceutical company’s stock after buying an additional 210,000 shares during the period. BioDelivery Sciences International comprises 1.0% of Broadfin Capital LLC’s portfolio, making the stock its 28th largest position. Broadfin Capital LLC owned 9.98% of BioDelivery Sciences International worth $9,448,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Stonepine Capital Management LLC purchased a new position in shares of BioDelivery Sciences International during the fourth quarter worth $4,551,000. Ameriprise Financial Inc. purchased a new position in shares of BioDelivery Sciences International during the second quarter worth $2,104,000. Baker BROS. Advisors LP purchased a new position in shares of BioDelivery Sciences International during the third quarter worth $567,000. Searle & CO. purchased a new position in shares of BioDelivery Sciences International during the third quarter worth $455,000. Finally, Tiverton Asset Management LLC boosted its position in shares of BioDelivery Sciences International by 206.1% in the third quarter. Tiverton Asset Management LLC now owns 180,417 shares of the specialty pharmaceutical company’s stock worth $487,000 after buying an additional 121,468 shares during the last quarter. Hedge funds and other institutional investors own 53.57% of the company’s stock.

Institutional Ownership by Quarter for BioDelivery Sciences International (NASDAQ:BDSI)

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) traded down 1.316% on Thursday, reaching $1.875. The company’s stock had a trading volume of 342,300 shares. BioDelivery Sciences International, Inc. has a 1-year low of $1.50 and a 1-year high of $4.39. The company’s market capitalization is $101.47 million. The stock has a 50 day moving average price of $1.89 and a 200-day moving average price of $2.18.

This report was reported by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be read at http://www.dailypolitical.com/2017/02/16/biodelivery-sciences-international-inc-bdsi-shares-bought-by-broadfin-capital-llc.html.

BDSI has been the topic of a number of research analyst reports. Zacks Investment Research cut BioDelivery Sciences International from a “buy” rating to a “hold” rating in a report on Wednesday, October 19th. FBR & Co set a $5.00 target price on BioDelivery Sciences International and gave the company a “buy” rating in a report on Thursday, February 2nd. Roth Capital set a $6.00 target price on BioDelivery Sciences International and gave the company a “buy” rating in a report on Monday, November 28th. Finally, Cantor Fitzgerald set a $3.00 target price on BioDelivery Sciences International and gave the company a “hold” rating in a report on Tuesday, January 17th. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company’s stock. BioDelivery Sciences International currently has a consensus rating of “Hold” and an average price target of $5.00.

BioDelivery Sciences International Company Profile

BioDelivery Sciences International, Inc is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using drug delivery technologies. The Company develops pharmaceutical products aimed principally in the areas of pain management and addiction.

5 Day Chart for NASDAQ:BDSI

Want to see what other hedge funds are holding BDSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BioDelivery Sciences International, Inc. (NASDAQ:BDSI).

Receive News & Ratings for BioDelivery Sciences International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioDelivery Sciences International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.